LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 229 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $316,000 | -12.2% | 5,277 | +6.0% | 0.00% | – |
| Q2 2023 | $360,000 | +65.1% | 4,976 | +68.1% | 0.00% | – |
| Q1 2023 | $218,000 | -34.5% | 2,961 | -40.4% | 0.00% | – |
| Q4 2022 | $333,000 | +82.0% | 4,971 | +135.1% | 0.00% | – |
| Q3 2022 | $183,000 | +8.9% | 2,114 | +12.4% | 0.00% | – |
| Q2 2022 | $168,000 | -45.1% | 1,881 | -30.8% | 0.00% | – |
| Q1 2022 | $306,000 | -62.5% | 2,717 | -48.6% | 0.00% | – |
| Q4 2021 | $817,000 | +41.3% | 5,289 | +27.6% | 0.00% | – |
| Q3 2021 | $578,000 | -80.1% | 4,145 | -81.3% | 0.00% | -100.0% |
| Q2 2021 | $2,905,000 | -5.8% | 22,146 | +9.5% | 0.00% | 0.0% |
| Q1 2021 | $3,083,000 | +3.5% | 20,230 | -32.4% | 0.00% | 0.0% |
| Q4 2020 | $2,978,000 | -0.0% | 29,940 | -4.2% | 0.00% | 0.0% |
| Q3 2020 | $2,979,000 | -14.7% | 31,252 | +0.1% | 0.00% | 0.0% |
| Q2 2020 | $3,492,000 | +67.1% | 31,215 | +8.6% | 0.00% | 0.0% |
| Q1 2020 | $2,090,000 | -28.4% | 28,735 | +2.7% | 0.00% | 0.0% |
| Q4 2019 | $2,918,000 | -41.2% | 27,986 | -43.8% | 0.00% | -50.0% |
| Q3 2019 | $4,960,000 | -50.2% | 49,826 | -42.9% | 0.00% | -50.0% |
| Q2 2019 | $9,963,000 | +30.1% | 87,281 | +43.3% | 0.00% | +33.3% |
| Q1 2019 | $7,656,000 | -7.6% | 60,909 | -0.3% | 0.00% | -25.0% |
| Q4 2018 | $8,290,000 | +1.1% | 61,083 | +104.5% | 0.00% | +33.3% |
| Q3 2018 | $8,197,000 | -46.1% | 29,867 | -59.3% | 0.00% | -57.1% |
| Q2 2018 | $15,219,000 | -9.2% | 73,462 | -27.6% | 0.01% | -12.5% |
| Q1 2018 | $16,752,000 | +14.3% | 101,430 | -5.2% | 0.01% | +33.3% |
| Q4 2017 | $14,653,000 | +9.6% | 107,028 | +9.0% | 0.01% | 0.0% |
| Q3 2017 | $13,365,000 | -34.4% | 98,151 | -41.6% | 0.01% | -45.5% |
| Q2 2017 | $20,388,000 | +112.6% | 167,943 | +85.4% | 0.01% | +120.0% |
| Q1 2017 | $9,590,000 | +566.4% | 90,606 | +540.0% | 0.01% | +400.0% |
| Q4 2016 | $1,439,000 | -26.4% | 14,157 | -26.0% | 0.00% | 0.0% |
| Q3 2016 | $1,954,000 | -41.7% | 19,139 | -31.8% | 0.00% | -50.0% |
| Q2 2016 | $3,350,000 | +91.2% | 28,082 | +71.7% | 0.00% | +100.0% |
| Q1 2016 | $1,752,000 | +177.2% | 16,360 | +180.8% | 0.00% | – |
| Q4 2015 | $632,000 | +31.4% | 5,826 | +3.8% | 0.00% | – |
| Q3 2015 | $481,000 | +4.6% | 5,613 | +23.2% | 0.00% | – |
| Q2 2015 | $460,000 | +25.7% | 4,557 | -3.9% | 0.00% | – |
| Q1 2015 | $366,000 | +12100.0% | 4,741 | +11463.4% | 0.00% | – |
| Q1 2014 | $3,000 | -99.8% | 41 | -99.9% | 0.00% | -100.0% |
| Q4 2013 | $1,608,000 | +26700.0% | 30,578 | +23421.5% | 0.00% | – |
| Q3 2013 | $6,000 | -68.4% | 130 | -73.6% | 0.00% | – |
| Q2 2013 | $19,000 | – | 492 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |